This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Readers have been asking for more molecules, so we started a new feature that highlights a few of the molecules…
Article
8 months ago ●
7 mins read
What is it? RMC-5552 is a potential first-in-class, bi-steric, mTOR1-selective inhibitor in Ph. I/IIb (NCT04774952, NCT05557292) as an IV agent…
molecule
2 months ago ●
3 mins read
A SETD2 inhibitor with Fast Track Status for hematological malignancies, a CNS-penetrating, ATP-competitive LRRK2 inhibitor for Parkinson’s disease, and an…
Article
8 months ago ●
1 min read
What is it? Inavolisib is a PI3Kα isoform-selective kinase inhibitor and monovalent degrader of the mutant p110α catalytic subunit of…
molecule
2 months ago ●
5 mins read
Product development is unique in biopharma in the degree of separation between product developers (R&D scientists) and end users (patients…
Article
8 months ago ●
10 mins read
A newly disclosed sGC activator in Ph. II for CKD/DKD. This month, researchers at BI reported promising preclinical results for…
molecule
2 months ago ●
4 mins read
Load More
